HK1 and neoplasm: The glycolytic enzyme HK2 has recently been found to perform nonglycolytic activities in cancer, including regulation of transcription [9], anti-apoptotic [48,49], scaffolding activities [14], and protein kinase activities mediating tumor immune evasion [36].